<VariationArchive VariationID="222074" VariationName="NM_002755.4(MAP2K1):c.175_177del (p.Lys59del)" VariationType="Deletion" Accession="VCV000222074" Version="5" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-14" DateCreated="2016-02-20" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="223772" VariationID="222074">
      <GeneList>
        <Gene Symbol="MAP2K1" FullName="mitogen-activated protein kinase kinase 1" GeneID="5604" HGNC_ID="HGNC:6840" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q22.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="66386912" stop="66491544" display_start="66386912" display_stop="66491544" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="66679210" stop="66783881" display_start="66679210" display_stop="66783881" Strand="+" />
          </Location>
          <OMIM>176872</OMIM>
          <Haploinsufficiency last_evaluated="2015-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MAP2K1">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2015-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MAP2K1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_002755.4(MAP2K1):c.175_177del (p.Lys59del)</Name>
      <CanonicalSPDI>NC_000015.10:66435118:AGAAG:AG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q22.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="66435119" stop="66435121" display_start="66435119" display_stop="66435121" variantLength="3" positionVCF="66435118" referenceAlleleVCF="CAGA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="66727457" stop="66727459" display_start="66727457" display_stop="66727459" variantLength="3" positionVCF="66727456" referenceAlleleVCF="CAGA" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>3-BP DEL, AAG, EX2</Name>
      </OtherNameList>
      <ProteinChange>K59del</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_725" sequenceAccession="LRG_725">
            <Expression>LRG_725:g.53249_53251del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002755.3" sequenceAccession="NM_002755" sequenceVersion="3" change="c.175_177delAAG">
            <Expression>NM_002755.3:c.175_177delAAG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.66435121_66435123del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.66435121_66435123del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.66727459_66727461del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.66727459_66727461del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008305.1" sequenceAccession="NG_008305" sequenceVersion="1" change="g.53249_53251del">
            <Expression>NG_008305.1:g.53249_53251del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002755.4" sequenceAccession="NM_002755" sequenceVersion="4" change="c.175_177del" MANESelect="true">
            <Expression>NM_002755.4:c.175_177del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002746.1" sequenceAccession="NP_002746" sequenceVersion="1" change="p.Lys59del">
            <Expression>NP_002746.1:p.Lys59del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA354831" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="176872.0004" DB="OMIM" />
        <XRef Type="rs" ID="869025339" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002755.4(MAP2K1):c.175_177del (p.Lys59del) AND not provided" Accession="RCV000207500" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2015-07-21" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_002755.4(MAP2K1):c.175_177del (p.Lys59del) AND Cardiofaciocutaneous syndrome 3" Accession="RCV002277569" Version="1">
        <ClassifiedConditionList TraitSetID="10539">
          <ClassifiedCondition DB="MedGen" ID="C3809006">Cardiofaciocutaneous syndrome 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2007-07-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_002755.4(MAP2K1):c.175_177del (p.Lys59del) AND RASopathy" Accession="RCV002515536" Version="2">
        <ClassifiedConditionList TraitSetID="9403">
          <ClassifiedCondition DB="MedGen" ID="C5555857">RASopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-02" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-02" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2016-02-20" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17551924</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29753091</ID>
        </Citation>
        <DescriptionHistory Dated="2022-08-28">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-08-28">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9403" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17678" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Noonan spectrum disorder</ElementValue>
                <XRef ID="genomeconnect_15815_622" DB="GenomeConnect, ClinGen" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">RASopathy</ElementValue>
                <XRef ID="MONDO:0021060" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">rasopathies</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="22213" />
                <XRef ID="22213" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="536391" DB="Orphanet" />
              <XRef ID="C5555857" DB="MedGen" />
              <XRef ID="MONDO:0021060" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10539" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17943" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cardiofaciocutaneous syndrome 3</ElementValue>
                <XRef ID="MONDO:0014113" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CFC3</ElementValue>
                <XRef Type="MIM" ID="615279" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15936" />
                <XRef ID="15936" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Cardiofaciocutaneous (CFC) syndrome is characterized by cardiac abnormalities (pulmonic stenosis and other valve dysplasias, septal defects, hypertrophic cardiomyopathy, rhythm disturbances), distinctive craniofacial appearance, and cutaneous abnormalities (including xerosis, hyperkeratosis, ichthyosis, keratosis pilaris, ulerythema ophryogenes, eczema, pigmented moles, hemangiomas, and palmoplantar hyperkeratosis). The hair is typically sparse, curly, fine or thick, woolly or brittle; eyelashes and eyebrows may be absent or sparse. Nails may be dystrophic or fast growing. Some form of neurologic and/or cognitive delay (ranging from mild to severe) is seen in all affected individuals. Neoplasia, mostly acute lymphoblastic leukemia, has been reported in some individuals.</Attribute>
                <XRef ID="NBK1186" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301365</ID>
                <ID Source="BookShelf">NBK1186</ID>
              </Citation>
              <XRef ID="1340" DB="Orphanet" />
              <XRef ID="C3809006" DB="MedGen" />
              <XRef ID="MONDO:0014113" DB="MONDO" />
              <XRef Type="MIM" ID="615279" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="492515" SubmissionDate="2015-12-22" DateLastUpdated="2016-02-20" DateCreated="2016-02-20">
        <ClinVarSubmissionID localKey="NM_002755.3:c.175_177delAAG|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000263048" DateUpdated="2016-02-20" DateCreated="2016-02-20" Type="SCV" Version="1" SubmitterName="Molecular Diagnostics Lab, Nemours Children's Health, Delaware" OrgID="28338" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-07-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17551924</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MAP2K1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_002755.3: exon 2</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.Lys59del</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="HGMD" ID="CD073663" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_002755.3:c.175_177delAAG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2454146" SubmissionDate="2020-04-21" DateLastUpdated="2020-05-04" DateCreated="2020-05-04">
        <ClinVarSubmissionID localKey="176872.0004_CARDIOFACIOCUTANEOUS SYNDROME 3" title="MAP2K1, 3-BP DEL, AAG, EX2_CARDIOFACIOCUTANEOUS SYNDROME 3" />
        <ClinVarAccession Accession="SCV001244680" DateUpdated="2020-05-04" DateCreated="2020-05-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2007-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In an 8-year-old girl (patient 144) with cardiofaciocutaneous syndrome-3 (CFC3; 615279), Gripp et al. (2007) identified a 3-bp deletion (AAG) in exon 2 of the MEK1 gene, resulting in deletion of a lysine (K59del) at the beginning of the protein kinase-like domain.</Attribute>
              <Citation>
                <ID Source="PubMed">17551924</ID>
              </Citation>
              <XRef DB="OMIM" ID="615279" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MAP2K1" />
          </GeneList>
          <Name>MAP2K1, 3-BP DEL, AAG, EX2</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP DEL, AAG, EX2</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="176872.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CARDIOFACIOCUTANEOUS SYNDROME 3</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6131484" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="4924809|MedGen:CN166718" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003442955" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">29753091</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17551924</ID>
          </Citation>
          <Comment>In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Experimental studies have shown that this variant affects MAP2K1 function (PMID: 29753091). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 222074). This variant has been observed in individual(s) with cardio-facio-cutaneous syndrome (PMID: 17551924). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This variant, c.175_177del, results in the deletion of 1 amino acid(s) of the MAP2K1 protein (p.Lys59del), but otherwise preserves the integrity of the reading frame.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MAP2K1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.66727457_66727459del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN166718" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2454146" TraitType="Disease" MappingType="Name" MappingValue="CARDIOFACIOCUTANEOUS SYNDROME 3" MappingRef="Preferred">
        <MedGen CUI="C3809006" Name="Cardiofaciocutaneous syndrome 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6131484" TraitType="Disease" MappingType="XRef" MappingValue="CN166718" MappingRef="MedGen">
        <MedGen CUI="C5555857" Name="RASopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="492515" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

